000028 国药一致
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(463,076)3,271,4682,937,1392,560,4311,655,181
投资活动产生之现金流量净额(77,078)(150,686)(135,435)(342,819)(455,532)
筹资活动产生之现金流量净额(1,313,853)(1,831,236)(2,407,642)(1,507,760)(1,871,641)
汇率变动对现金及现金等价物的影响(74)(1,196)(941)(1,190)391
现金及现金等价物净增加/(减少)(1,854,081)1,288,350393,121708,661(671,601)
期初现金及现金等价物余额7,123,6455,835,2945,442,1734,733,5125,405,113
期末现金及现金等价物余额5,269,5647,123,6455,835,2945,442,1734,733,512